OLIG 2 ( BHLHB 1 ) , a bHLH Transcription Factor , Contributes to Leukemogenesis in Concert with LMO 1
暂无分享,去创建一个
Ying-Wei Lin | S. Nimer | N. Iscove | P. Aplan | Yingwei Lin | M. Barbara | Peter D. Aplan | Stephen D. Nimer | Ramona Deveney | Mary Barbara | Christopher Slape | Norman N. Iscove | C. Slape | Ramona Deveney
[1] C. James,et al. Amplification of the Platelet‐Derived Growth Factor Receptor‐A (PDGFRA) Gene Occurs in Oligodendrogliomas with Grade IV Anaplastic Features , 2000, Journal of neuropathology and experimental neurology.
[2] Gerard Brady,et al. Errata , 1897, Current Biology.
[3] Joanne Chan,et al. Sonic Hedgehog–Regulated Oligodendrocyte Lineage Genes Encoding bHLH Proteins in the Mammalian Central Nervous System , 2000, Neuron.
[4] Jean-Yves Delattre,et al. OLIG2 as a specific marker of oligodendroglial tumour cells , 2001, The Lancet.
[5] N. Harris,et al. Bethesda proposals for classification of lymphoid neoplasms in mice. , 2002, Blood.
[6] B. Hadland,et al. A requirement for Notch1 distinguishes 2 phases of definitive hematopoiesis during development. , 2004, Blood.
[7] N. Iscove,et al. Hematopoietic stem cells engraft in mice with absolute efficiency , 2003, Nature Immunology.
[8] David J Anderson,et al. Identification of a Novel Family of Oligodendrocyte Lineage-Specific Basic Helix–Loop–Helix Transcription Factors , 2000, Neuron.
[9] Zhenhua Zhang,et al. NUP98-HOXD13 transgenic mice develop a highly penetrant, severe myelodysplastic syndrome that progresses to acute leukemia. , 2005, Blood.
[10] G. Sclar,et al. Thymic overexpression of Ttg-1 in transgenic mice results in T-cell acute lymphoblastic leukemia/lymphoma , 1992, Molecular and cellular biology.
[11] D. van der Kooy,et al. Notch pathway molecules are essential for the maintenance, but not the generation, of mammalian neural stem cells. , 2002, Genes & development.
[12] Andrew P. Weng,et al. Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia , 2004, Science.
[13] H. Hsu,et al. Enhancer-binding activity of the tal-1 oncoprotein in association with the E47/E12 helix-loop-helix proteins , 1991, Molecular and cellular biology.
[14] R. Benezra,et al. High incidence of T-cell tumors in E2A-null mice and E2A/Id1 double-knockout mice , 1997, Molecular and cellular biology.
[15] M. Nakafuku,et al. Dynamic expression of basic helix-loop-helix Olig family members: implication of Olig2 in neuron and oligodendrocyte differentiation and identification of a new member, Olig3 , 2000, Mechanisms of Development.
[16] K. Gross,et al. Disordered T-Cell Development and T-Cell Malignancies in SCL LMO1 Double-Transgenic Mice: Parallels with E2A-Deficient Mice , 1999, Molecular and Cellular Biology.
[17] E. Lander,et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. , 2002, Cancer cell.
[18] F. Lee,et al. The E2A and tal-1 helix-loop-helix proteins associate in vivo and are modulated by Id proteins during interleukin 6-induced myeloid differentiation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[19] M. Nakafuku,et al. Combinatorial Roles of Olig2 and Neurogenin2 in the Coordinated Induction of Pan-Neuronal and Subtype-Specific Properties of Motoneurons , 2001, Neuron.
[20] S. Pfaff,et al. Olig2 and Ngn2 function in opposition to modulate gene expression in motor neuron progenitor cells. , 2005, Genes & development.
[21] Min Xu,et al. Notch‐induced E2A ubiquitination and degradation are controlled by MAP kinase activities , 2003, The EMBO journal.
[22] M. Caligiuri,et al. Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia , 2004, The Lancet.
[23] J. Kutok,et al. Notch Oncoproteins Depend on γ-Secretase/Presenilin Activity for Processing and Function* , 2004, Journal of Biological Chemistry.
[24] J. Aster,et al. Notch1 expression in early lymphopoiesis influences B versus T lineage determination. , 1999, Immunity.
[25] D. Louis,et al. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. , 2001, Genes & development.
[26] J. Downing,et al. Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice. , 2002, Blood.
[27] P. D. de Jong,et al. The t(14;21)(q11.2;q22) chromosomal translocation associated with T-cell acute lymphoblastic leukemia activates the BHLHB1 gene. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[28] J. Sklar,et al. Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles , 1996, The Journal of experimental medicine.
[29] Jon C. Aster,et al. Essential Roles for Ankyrin Repeat and Transactivation Domains in Induction of T-Cell Leukemia by Notch1 , 2000, Molecular and Cellular Biology.
[30] M. Trevisan,et al. Resolution of pluripotential intermediates in murine hematopoietic differentiation by global complementary DNA amplification from single cells: confirmation of assignments by expression profiling of cytokine receptor transcripts. , 2001, Blood.
[31] K. Hoang-Xuan,et al. OLIG‐1 and 2 gene expression and oligodendroglial tumours , 2002, Neuropathology and applied neurobiology.
[32] D. Rowitch,et al. Oligodendrocyte lineage genes (OLIG) as molecular markers for human glial brain tumors , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[33] N. Iscove,et al. Hematopoietic stem cells expand during serial transplantation in vivo without apparent exhaustion , 1997, Current Biology.
[34] D A Scudiero,et al. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. , 1988, Cancer research.
[35] D. Scudiero,et al. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. , 1991, Journal of the National Cancer Institute.
[36] K. Gross,et al. An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T‐cell malignancies in transgenic mice , 1997, The EMBO journal.
[37] James D. Griffin,et al. Growth Suppression of Pre-T Acute Lymphoblastic Leukemia Cells by Inhibition of Notch Signaling , 2003, Molecular and Cellular Biology.
[38] David J. Anderson,et al. The bHLH Transcription Factor Olig2 Promotes Oligodendrocyte Differentiation in Collaboration with Nkx2.2 , 2001, Neuron.
[39] M. Götz,et al. Regionalization and fate specification in neurospheres: the role of Olig2 and Pax6 , 2004, Molecular and Cellular Neuroscience.
[40] S. Orkin,et al. The SCL gene product: a positive regulator of erythroid differentiation. , 1992, The EMBO journal.
[41] W. Richardson,et al. Spinal cord oligodendrocytes develop from ventrally derived progenitor cells that express PDGF alpha-receptors. , 1996, Development.
[42] T. Kondo,et al. Nuclear export of OLIG2 in neural stem cells is essential for ciliary neurotrophic factor–induced astrocyte differentiation , 2004, The Journal of cell biology.
[43] N. Spassky,et al. Sonic hedgehog-dependent emergence of oligodendrocytes in the telencephalon: evidence for a source of oligodendrocytes in the olfactory bulb that is independent of PDGFRalpha signaling. , 2001, Development.
[44] J. Sklar,et al. TAN-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms , 1991, Cell.